Incyte to Report Fourth Quarter and Year-end Financial Results
WILMINGTON, Del.--(BUSINESS WIRE)--Jan 24, 2019--Incyte Corporation (Nasdaq:INCY) announced today that it has scheduled its fourth quarter and year-end 2018 financial results conference call and webcast for 8:00 a.m. ET on Thursday, February 14, 2019.
The schedule for the press release and conference call/webcast is as follows:
If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and the dial-in number for international callers is +1-201-612-7415. To access the replay you will need the conference ID number 13686537.
The live webcast with slides can be accessed at www.incyte.com under For Investors, Events and Presentations and will be available for replay for 30 days.
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit the Company’s website at www.incyte.com.
Follow @Incyte on Twitter at https://twitter.com/Incyte.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190124005001/en/
Michael Booth, DPhil
+1 302 498 5914
+1 302 498 6171
KEYWORD: UNITED STATES NORTH AMERICA DELAWARE
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL
SOURCE: Incyte Corporation
Copyright Business Wire 2019.
PUB: 01/24/2019 08:00 AM/DISC: 01/24/2019 08:00 AM